pom tirzepatide #weightloss #diabetes #gp #obesity | Jim McMorran Zepbound® Tirzepatide Weight Loss Program

As Ozempics popularity soared, so too did reports of severe gastrointestinal side effects the very injuries now driving a wave of litigation

A landmark study exploring the cardiovascular safety and benefits of Semaglutide in a large cohort of patients with type 2 diabetes

The plate method for semaglutide users Forget complicated calorie counting or macro tracking apps if they overwhelm you

The SELECT trial (N=17,604) demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a median 34.2 months in patients with overweight or obesity and pre-existing cardiovascular disease, independent of glycemic status [12]

Why PlexusDx Offers Insurance-Free GLP-1 Access PlexusDx specializes in prescription GLP-1 compounds made by licensed 503A compounding pharmacies, eliminating the need to navigate insurance approval timelines or meet coverage restrictions